ID28304A - Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik - Google Patents

Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik

Info

Publication number
ID28304A
ID28304A IDW20001216A ID20001216A ID28304A ID 28304 A ID28304 A ID 28304A ID W20001216 A IDW20001216 A ID W20001216A ID 20001216 A ID20001216 A ID 20001216A ID 28304 A ID28304 A ID 28304A
Authority
ID
Indonesia
Prior art keywords
complexion
better
molecular dispersion
bio availability
bio
Prior art date
Application number
IDW20001216A
Other languages
English (en)
Indonesian (id)
Inventor
Surendra A Sangekar
Ping I Lee
Amin A Nomier
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ID28304A publication Critical patent/ID28304A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20001216A 1997-12-22 1998-12-17 Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik ID28304A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99716897A 1997-12-22 1997-12-22

Publications (1)

Publication Number Publication Date
ID28304A true ID28304A (id) 2001-05-10

Family

ID=25543717

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001216A ID28304A (id) 1997-12-22 1998-12-17 Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik

Country Status (27)

Country Link
EP (1) EP1039908B1 (de)
JP (2) JP2001526227A (de)
KR (1) KR100597331B1 (de)
CN (1) CN1116039C (de)
AR (1) AR017436A1 (de)
AT (1) ATE260105T1 (de)
AU (1) AU761994C (de)
BR (1) BR9813728A (de)
CA (1) CA2315685C (de)
CO (1) CO4970793A1 (de)
CZ (1) CZ295956B6 (de)
DE (1) DE69821984T2 (de)
DK (1) DK1039908T3 (de)
ES (1) ES2214757T3 (de)
HU (1) HU229052B1 (de)
ID (1) ID28304A (de)
IL (1) IL136460A0 (de)
MY (1) MY126580A (de)
NO (1) NO327383B1 (de)
NZ (1) NZ504834A (de)
PE (1) PE20000012A1 (de)
PL (1) PL192423B1 (de)
PT (1) PT1039908E (de)
SK (1) SK285662B6 (de)
TW (1) TW527196B (de)
WO (1) WO1999032118A1 (de)
ZA (1) ZA9811592B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) * 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
JP2004534812A (ja) 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物
EP1492508A4 (de) * 2002-03-04 2009-05-06 Teva Pharma Dosierformen mit kontrollierter freisetzung
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008136392A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. 経口投与用製剤
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms
ES3063790T3 (en) 2015-06-09 2026-04-20 Lonza Sales Ag Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
EP0214092A1 (de) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Absorption von psychoaktiven 2-Aryl-pyrazoloquinolinen in Form einer festen Molekulardispersion in Polyvinylpyrrolidon
EP0617612B1 (de) * 1991-12-18 1997-09-10 Warner-Lambert Company Verfahren für die herstellung einer festen dispersion
JPH0848632A (ja) * 1994-08-08 1996-02-20 Kanebo Ltd エトポシドを含有する固形組成物および固形製剤
IL125062A (en) * 1995-12-22 2003-11-23 Schering Corp Tricyclic amides and pharmaceutical compositions containing them for inhibition of g-protein function and for treatment of proliferative diseases
ATE273002T1 (de) * 1996-06-28 2004-08-15 Schering Corp Feste lösung eines fungizids mit erhöhter bioverfügbarkeit

Also Published As

Publication number Publication date
PL341344A1 (en) 2001-04-09
AU761994B2 (en) 2003-06-12
MY126580A (en) 2006-10-31
PE20000012A1 (es) 2000-01-18
KR100597331B1 (ko) 2006-07-10
ES2214757T3 (es) 2004-09-16
HUP0100850A3 (en) 2002-12-28
PL192423B1 (pl) 2006-10-31
AU761994C (en) 2004-01-08
SK285662B6 (sk) 2007-05-03
HK1027040A1 (en) 2001-01-05
ZA9811592B (en) 1999-06-17
BR9813728A (pt) 2000-10-10
HU229052B1 (en) 2013-07-29
NO20003235D0 (no) 2000-06-21
CO4970793A1 (es) 2000-11-07
DE69821984D1 (de) 2004-04-01
NO20003235L (no) 2000-07-27
IL136460A0 (en) 2001-06-14
CN1282245A (zh) 2001-01-31
JP2001526227A (ja) 2001-12-18
NO327383B1 (no) 2009-06-22
CN1116039C (zh) 2003-07-30
JP2010059212A (ja) 2010-03-18
EP1039908B1 (de) 2004-02-25
CA2315685A1 (en) 1999-07-01
WO1999032118A1 (en) 1999-07-01
KR20010033397A (ko) 2001-04-25
HUP0100850A2 (hu) 2001-10-28
TW527196B (en) 2003-04-11
DE69821984T2 (de) 2004-12-30
AR017436A1 (es) 2001-09-05
NZ504834A (en) 2001-12-21
CZ20002304A3 (cs) 2001-04-11
PT1039908E (pt) 2004-06-30
SK8962000A3 (en) 2001-07-10
AU1814399A (en) 1999-07-12
CZ295956B6 (cs) 2005-12-14
DK1039908T3 (da) 2004-05-03
CA2315685C (en) 2008-02-05
EP1039908A1 (de) 2000-10-04
ATE260105T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
ID16926A (id) Komposisi-komposisi antijamur dengan ketersediaan biologis yang lebih baik
PT1035830E (pt) Composicoes cosmeticas com dibenzilideno-sorbitol e silicones com grupos funcionais
ID21085A (id) Perkaitan dan bidang pemisah listrik untuk perlengkapan komunikasi pemakaian pribadi
ATE189381T1 (de) Starkschäumendes haarfrisiershampoo
ID24370A (id) Polimer-polimer monoviniliden dengan tumbukan yang tinggi dan kehalusan yang tinggi
ID18210A (id) Campuran zat warna dispersi
FI970038A0 (fi) Kosteuttava valmiste
DE69820519D1 (de) Haarkosmetische Zubereitung
FI974646A0 (fi) Utjaemning av stoerningar i mobilkommunicationssystem
ID23159A (id) Wafer dan pembuatannya
ID20268A (id) Landasan ski di dalam ruangan, serta metoda dan pengontrol landasan ski di dalam ruangan
ID28304A (id) Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik
ID22894A (id) Dispersi berair
DE69815835D1 (de) Schäumbare polymerzusammensetzung
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
DE59700410D1 (de) Haarreinigungsmittel mit Festigungseigenschaften
DE69814346D1 (de) Herstellung von phosphatestern
DE59711315D1 (de) Herstellung von Polybenzoxazol- und Polybenzothiazol-Vorstufen
ID17814A (id) Lintasan elevator yang memiliki n kabin, 2n landasan dan 3n geladak
FI961038A0 (fi) Parannuksia matkaviestinverkoissa tai niihin liittyen
FI956005A0 (fi) Tastaturstruktur som minskar elektromagnetisk stoerning
DE19881242D2 (de) Erlebnis-Boot
FR2760746B3 (fr) Nouveaux acylaminoacides
ITRM960052A0 (it) Peptidi e loro usi nella terapia della malattia celiaca
ID28337A (id) Interpolimer-interpolimer yang menjadi keras setelah dipanaskan dan busa-busa dari interpolimer tersebut